|
| Interactions: | Molecule : Carbamazepine
Adverse Effect: Concomitant administration results in increased clearance of Olanzapine due to the induction of CYP1A2
# Clinical Management: Monitor for the therapeutic effects and adjust the dose accordingly.
Molecule : Fluvoxamine
Adverse Effect: Concomitant administration results in decreased clearance of Olanzapine due to the inhibition of CYP1A2
# Clinical Management: Monitor for the therapeutic effects and adjust the dose accordingly.
Molecule : Omeprazole
Adverse Effect: Concomitant administration results in increased clearance of Olanzapine due to the induction of CYP1A2 or glucuronyl transferase enzyme
# Clinical Management: Monitor for the therapeutic effects and adjust the dose accordingly. |
|
|